Patents Assigned to Roche Diagnostics Operations, Inc.
  • Patent number: 11635438
    Abstract: Methods, systems and kits for the early diagnosis or prediction of systemic inflammatory response syndrome (SIRS) including sepsis in asymptomatic patients, such as patients undergoing a surgical intervention, are provided. Some embodiments include a method and system for the detection or diagnosis of SIRS, or detection or diagnosis of a risk to suffer from or develop SIRS, in an asymptomatic patient comprising the steps of determining the level of IL-6 (or a variant thereof) in a sample from the patient; comparing the level of IL-6 (or a variant thereof) to a reference level; detecting or diagnosing SIRS or diagnosing a risk to suffer from or develop SIRS, wherein the sample is isolated at least 2 times at short intervals and the determining and comparing steps are both repeated for each sample. Also provided are methods, systems and kits for therapy monitoring and mortality prediction.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: April 25, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Susanne Grueb, Nicole Neuboeck, Freyja-Maria Smolle-Juettner, Annelie-Martina Weinberg
  • Patent number: 11630116
    Abstract: An automated method for determining a coagulation result of a biological sample is presented. The method includes obtaining a time series representing measurement data of a sample. The time series spans a period in which a clotting reaction is supposed to take place. The method includes obtaining a global model function configured to model measurement data of a sample in which a clotting reaction takes place. The global model function is configured to model the measurement data as a sigmoidal shape with at least one inflection point. The absolute value of the maximum curvature of the sigmoidal shape is larger on one side of the at least one inflection point than on the other side. The method includes fitting the model function to the time series representing measurement data to obtain a fitted model function and determining a coagulation result of the sample based on the fitted model function.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: April 18, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Rolf Knobel
  • Publication number: 20230116054
    Abstract: A method of assigning an additional test to an existing aliquot sample tube or to a primary sample tube in a laboratory automation system is presented. The laboratory automation system comprises a workflow control unit and analytical laboratory devices in communication with the workflow control unit. The method comprises receiving an additional test request for the existing aliquot sample tube after processing of the existing aliquot sample tube has started, determining if the existing aliquot sample tube is at a retrievable target, waiting until the existing aliquot sample tube reaches a retrievable target if not at a retrievable target, determining if an aliquot timeout has occurred once the existing aliquot sample tube is at a retrievable target, reassigning the addition test to the primary sample tube if an aliquot timeout has occurred, and performing the additional test from the existing aliquot sample tube if no aliquot timeout has occurred.
    Type: Application
    Filed: August 24, 2022
    Publication date: April 13, 2023
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Carlos Fernandez Gulias, Vanesa Leon Pujola, Laura Pellitero Cornet, Pau Roura Brun, Werner Smit, Gemma Urrutia Jou, Chye Yin Priscillia Tan, Moritz von Hopffgarten
  • Patent number: 11618892
    Abstract: The present invention relates to a mutant reverse transcriptase (RT) with increased thermal stability relative to the wildtype, a nucleic acid encoding the mutant RT, a cell comprising the mutant RT or the nucleic acid, a kit comprising the mutant RT, the use of the mutant RT for cDNA synthesis, method for reverse transcription of RNA comprising synthesizing cDNA with the use of the mutant RT and a method for detecting an RNA marker in a sample with the use of the mutant RT.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: April 4, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Christian Helmut Bell, Harald Sobek, Heiko Walch, Kiyoshi Yasukawa, Misato Baba
  • Patent number: 11619641
    Abstract: A container carrier for carrying a sample container along a track is presented. The container carrier comprises a holding portion for receiving and holding a sample container and a base portion. A radio frequency identification (RFID) tag containing identifying information is provided with an antenna for wireless communication of the RFID tag with a reader device of the diagnostics system to read the identifying information. The RFID tag is on the holding portion. An arrangement for a diagnostics system is provided comprising container carriers and a track with a transport mechanism for moving the container carriers along a transportation lane. The transport mechanism defines a transport plane along which the container carriers move. A reader device reads the identifying information from the RFID tags. The reader device comprising a reader antenna above the transport plane to generate and emit a reader field for wireless communication with the RFID tag's antenna.
    Type: Grant
    Filed: October 21, 2020
    Date of Patent: April 4, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Riccardo Leone Benedetti
  • Publication number: 20230100112
    Abstract: A distribution system is disclosed. The distribution system comprises a transport plan comprising logical positions, carriers for transporting objects, a drive system to move the carriers on the transport plan between logical positions, a control system configured for controlling the carriers to move on a planned route from a start position to a final destination position on the transport plane via logical positions, wherein the control system comprises a routing system configured for calculating routes for at least two carriers on the transport plane by modeling the transport plane with graphs of nodes, wherein the routing system is configured for calculating the planned routes considering balancing of surface usage of the transport plane, and wherein the routing system is configured for considering temporal blocking of logical positions and/or a considering variable move length and/or considering a variable reservation length.
    Type: Application
    Filed: September 14, 2022
    Publication date: March 30, 2023
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Edwin Oosterbroek, Nicolas Sillitoe
  • Publication number: 20230093550
    Abstract: A distribution system comprising a transport plane for distributing objects and carriers for transporting the objects. A drive system moves the carriers on the transport plane. A control system of the distribution system is configured to control the carriers to move on a planned route from a start position to a final destination position on the transport plane. The control system comprises a routing system configured to calculate the planned route for at least two carriers on the transport plane by modeling the transport plane with nodes and graphs and using a windowed hierarchical cooperative informed search algorithm. The routing system is configured to determine reserved and free time windows for each node. The routing system is configured to assign an individual reservation length to each carrier for the next move on free time windows and assigns an infinite reservation time to the node of a logical position.
    Type: Application
    Filed: November 3, 2022
    Publication date: March 23, 2023
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Edwin Oosterbroek, Nicolas Seungoon Sillitoe
  • Patent number: 11592454
    Abstract: A method of handling laboratory sample containers by a laboratory sample container handling system is presented. The method comprises providing a laboratory sample container comprising an assigned ID information to the laboratory sample container handling system, reading the assigned ID information, checking, if the read ID information is unique or not unique within the laboratory sample container handling system, and if the read ID information (2) is not unique within the laboratory sample container handling system, assigning a new ID information to the laboratory sample container. The new ID information is unique within the laboratory sample container handling system.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: February 28, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Werner Smit, Florian Weber, Bauke Sjoerd Hollander, Riccardo Triunfo, Chye Yin Priscillia Tan
  • Publication number: 20230059570
    Abstract: A method for operating a laboratory automation system, having: a control device and a transport system with carriers and a first empty carrier queue provided with a first fixed number of queue spaces, each assignable an empty carrier; the method comprising: providing additional queue spaces, each assignable an empty carrier, assigning a first number of additional queue spaces from the additional queue spaces to the first empty carrier queue, operating the first empty carrier queue with the first fixed number of queue spaces plus the first number of additional queue spaces, assigning, in response to receiving operation data in the control device, a second number of additional queue spaces from the additional queue spaces to the first empty carrier queue and operating the first empty carrier queue with the first fixed number of queue spaces plus the second number of additional queue spaces. Further, a laboratory automation system is provided.
    Type: Application
    Filed: July 28, 2022
    Publication date: February 23, 2023
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Ole Lambaek, Dominik Schnarwiler, Bert Taeymans
  • Publication number: 20230058833
    Abstract: A method of routing test samples during periods of laboratory disruption in a laboratory system is disclosed. The method comprises determining that a laboratory device is unavailable, masking a target laboratory device so that test samples are not sent to the target laboratory device and test samples cannot be retrieved from the target laboratory device, rerouting test samples from the target laboratory device to a buffer, calculating a new laboratory workflow after the laboratory device becomes available, unmasking the target laboratory device after the new laboratory workflow is calculated, and retrieving the test samples from buffer and sending the test samples to the target laboratory device.
    Type: Application
    Filed: August 1, 2022
    Publication date: February 23, 2023
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Carlos Fernández Gulias, Vanesa León Pujolà, Laura Pellitero Cornet, Pau Roura Brun, Werner Smit, Chye Yin Priscillia Tan, Gemma Urrutia Jou, Moritz von Hopffgarten
  • Patent number: 11585791
    Abstract: A method for monitoring an analyzer including a liquid chromatography device (LC) having at least two liquid chromatography (LC) streams, the method including continuously monitoring one or more parameters in measurement data of samples in each of the at least two LC streams, the one or more parameters being independent of an analyte concentration of the respective sample, determining if the one or more monitored parameters show an expected behavior and triggering a response upon detection that the one or more monitored parameters deviate from the expected behavior.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: February 21, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Albert Geiger, Daniel Intelmann, Ruediger Laubender, Julian Michely, Kirill Tarasov
  • Patent number: 11585811
    Abstract: A method for detecting an analyte involving a) contacting the analyte, a capture agent and a solid surface to form a capture complex attached to a solid surface, b) cleaving at least one covalent bond within the analyte and/or within said capture agent in the capture complex and, thereby, releasing the analyte or a fragment thereof from the capture complex, and c) detecting at least one fragment of the analyte and, thereby, detecting the analyte is disclosed herein. A kit having i) a capture agent binding to an analyte; and ii) an agent cleaving at least one covalent bond within the analyte and/or within the capture agent; and to the use of a protease for releasing fragments of an analyte for detecting the analyte, wherein the analyte is bound to a solid surface via a capture agent is also disclosed herein.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: February 21, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Uwe Kobold, Robert Lang, Andreas Leinenbach
  • Publication number: 20230051070
    Abstract: A sample input interface for inputting samples into a detecting unit of an in-vitro diagnostic analyzer. The sample input interface comprises a sample input port comprising an outer input-port side configured for plugging-in an open end of a sample container and an inner input-port side, an aspiration needle comprising an upstream end and a downstream end, where the downstream end is fluidically connected or connectable to the detecting unit and where the upstream end is configured to alternately couple to the inner input-port side and to a fluid supply port. The outer input-port side is further configured to alternately couple to a fluid supply port while the upstream end of the aspiration needle is coupled to the inner input-port side in order to rinse the sample input port with fluid aspirated by the aspiration needle from a fluid supply unit via the sample input port.
    Type: Application
    Filed: July 22, 2022
    Publication date: February 16, 2023
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Marco Baschnagel, Fabian Geiger, Milenko Kostadinovic, Robert Kueffer
  • Patent number: 11579156
    Abstract: A method to provide control samples for validating a diagnostic test within a laboratory system is presented. The laboratory system comprises an aliquoting device, a storage, a transport system, at least two analyzers, and a control unit. A total number of control sample aliquots and an aliquot volume for each control sample aliquot is determined based on a validation time schedule. A provided total control sample volume is aliquoted into the determined total number of control sample aliquots with the determined aliquot volumes. The generated control sample aliquots are transported to one or more of the at least two analyzers according to the validation time schedule.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: February 14, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Michael Glauser, Urs Vollenweider
  • Patent number: 11581178
    Abstract: A mass spectrometry (MS) apparatus is provided. The MS apparatus includes a mass spectrometer, an ionization source coupled to the mass spectrometer, and a flow injection system (FIS) coupled to the ionization source. The ionization source is configured to provide an ionized gas flow of an analyte towards an entrance of the mass spectrometer. The ionization source is further configured to provide a second gas flow of a second gas. The MS apparatus is configured to measure a mass spectrometer (MS) signal of the analyte. The MS apparatus is further configured to analyze a dependency of the MS signal of the analyte versus a parameter of the second gas flow or a state of the second gas flow and to determine a condition of the apparatus based on the analyzed dependency.
    Type: Grant
    Filed: November 5, 2021
    Date of Patent: February 14, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Robert Lang, Stefan Quint, Gabriele Punzmann
  • Patent number: 11581071
    Abstract: A laboratory system for analyzing biological samples is presented. The laboratory system comprises a plurality of laboratory instruments configured to receive and identify biological samples and to query a laboratory control unit for a processing order indicative of processing steps to be carried out on the biological sample. The laboratory control unit is configured to validate sequence of queries from the plurality of laboratory instruments against a valid query sequence pattern.
    Type: Grant
    Filed: August 20, 2019
    Date of Patent: February 14, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Armin Birrer, Marco Maetzler, André Peter, Ole Lambaek
  • Publication number: 20230038084
    Abstract: A system for providing cyber protection to medical devices in a medical environment is presented. The system comprises a medical device comprising software services, a backend server to maintain and provide software updates to medical devices, and an interface proxy box connected to the medical device and in communication with the backend server. The interface proxy box determines the software services resident on the medical device. The interface proxy box installs the software services determined to be resident on the medical device on the interface proxy box and configures the installed software services to match the software services resident on the medical device. The interface proxy box communicates periodically with the backend server and receives and applies security updates to the software services installed and configured on the interface proxy box. The medical device utilizes the updated software services on the interface proxy box.
    Type: Application
    Filed: October 18, 2022
    Publication date: February 9, 2023
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Richard Salin, Alejandro Morcillo Montejo
  • Publication number: 20230037141
    Abstract: The present disclosure is related to an analytical system comprising a liquid chromatographic (LC) system comprising a plurality of fluidic streams alternately connectable to a common detector via a stream-selection valve connected to the detector via a valve-to-detector conduit. The analytical system further comprises a wash pump fluidically connected to the stream-selection valve and configured to connect to the valve-to-detector conduit between two consecutive fluidic streams in order to wash liquid from a previous fluidic stream out of the valve-to-detector conduit before liquid from a subsequent fluidic stream enters the valve-to-detector conduit. An analytical method comprising switching between the fluidic streams and washing in between is also disclosed.
    Type: Application
    Filed: October 13, 2022
    Publication date: February 2, 2023
    Applicants: ROCHE DIAGNOSTICS OPERATIONS, INC., HITACHI HIGH-TECH CORPORATION
    Inventors: Stefan Quint, Tibor Toth, Aart Pieter Van Doorn, Yuichiro Hashimoto
  • Patent number: 11567079
    Abstract: The invention concerns soluble and antigenic HTLV p24 variants that can be fused to chaperones and their use in diagnostic applications such as immunoassays for detecting antibodies against HTLV-I or HTLV-II in an isolated biological sample. In particular, the invention relates to a soluble HTLV-I or HTLV-II p24 antigen comprising either the N- or the C-terminal domain of p24 and lacking the other domain. Moreover, the invention covers recombinant DNA molecules encoding these HTLV-I and -II fusion antigens as well as their recombinant production using expression vectors and host cells transformed with such expression vectors. In addition, the invention focuses on compositions of these HTLV p24 antigens with HTLV gp21 antigen and on an immunoassay method for detection of HTLV antibodies using the antigens of the invention. Also the use of HTLV p24 antigens in an in vitro diagnostic assay as well as a reagent kit for detection of anti-HTLV-antibodies comprising said HTLV antigens is encompassed.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: January 31, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Elke Faatz, Christian Scholz, Peter Muench
  • Publication number: 20230028525
    Abstract: A computer-implemented method of generating training data to be used to train a machine learning model for generating a segmentation mask of an image containing overlapping particles. Training data is generated from sparse particle images which contain no overlaps. Generating masks for non-overlapping particles is generally not a problem if the particles can be identified clearly; in many cases simple methods such as thresholding already yield usable masks. The sparse images can then be combined to images which contain artificial overlaps. The same can be done for the masks as well which yields a large amount of training data, because of the many combinations which can be created from just a small set of images. The method is simple yet effective and can be adapted to many domains for example by adding style-transfer to the generated images or by including additional augmentation steps.
    Type: Application
    Filed: July 18, 2022
    Publication date: January 26, 2023
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Nils Bruenggel, Patrick Conway, Pascal Vallotton